Concepedia

Joyce Massengill

JM

Statistics

Publications

6

Citations

976

H-Index

6

Active since

1983

Affiliations

University of Arkansas for Medical Sciences(Current)

National Center for Toxicological Research

Lawrence Livermore National Laboratory

John L. McClellan Memorial Veterans Hospital

Joyce Massengill is an author at University of Arkansas for Medical Sciences specializing in pharmacology, medicine, and cancer metabolism.

Publications per year

1983–1999

6

Publications

6

Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites

Marguerite A. Butler, Nicholas P. Lang, J.F. Young et al. · Pharmacogenetics · 1992 · 418 citations

, , +17

Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps.

Nicholas P. Lang, Marguerite A. Butler, Joyce Massengill et al. · PubMed · 1994 · 392 citations

, , +17

The identification of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans

Michael Malfatti, Kristen S. Kulp, Mark G. Knize et al. · Carcinogenesis · 1999 · 100 citations

, , +15

Determination of Carcinogenic Arylamine N-Oxidation Phenotype in Humans by Analysis of Caffeine Urinary Metabolites

Marguerite A. Butler, Nicholas P. Lang, John F. Young et al. · 1990 · 27 citations

, , +13

In vivo human metabolism of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

Nicholas P. Lang, Susan Nowell, Michael Malfatti et al. · Cancer Letters · 1999 · 26 citations

, , +7

1–5 of 6